/
NASA Discovers Exoplanet Using Northrop Grumman-Built James Webb Space Telescope; Mark Clampin Quoted
Published on
NASA Discovers Exoplanet Using Northrop Grumman-Built James Webb Space Telescope; Mark Clampin Quoted

Researchers at NASA have validated the existence of a planet orbiting another star using the Northrop Grumman-developed James Webb Space Telescope.

The exoplanet marks NASA’s first such discovery made using the Webb telescope and measures at about 99 percent of Earth’s diameter, the agency said on Thursday.

“Webb is bringing us closer and closer to a new understanding of Earth-like worlds outside our solar system, and the mission is only just getting started,” said Mark Clampin, Astrophysics Division director at NASA Headquarters in Washington.

“These first observational results from an Earth-size, rocky planet open the door to many future possibilities for studying rocky planet atmospheres with Webb,” Clampin emphasized.

Classified as LHS 475 b, the exoplanet was a target of interest from NASA’s Transiting Exoplanet Survey Satellite. It is located in the constellation Octans, which is 41 light-years away, and orbits its star in just two Earth-days.

Data from the observatory indicates that the LHS 475 b is a terrestrial planet that is warmer than Earth by a few hundred degrees. The team is still working to confirm its atmospheric composition.

/
Col. Eric Felt Says Commercial Space Platforms Key to Maintaining U.S. Technological Edge
Published on
Col. Eric Felt Says Commercial Space Platforms Key to Maintaining U.S. Technological Edge

Col. Eric Felt, director of space architecture and integration at the U.S. Space Force, said investments in high-priority technologies and commercially available platforms are instrumental to maintaining the U.S. technological leadership in the space domain, SpaceNews reported Wednesday.

“What’s so exciting to the Space Force and the space acquisition community about all this commercial innovation is that we can use it to maintain our technology lead, and deter conflict with our competitors,” Felt said.

Speaking at the National Defense Industrial Association’s “State of the Space Industrial Base” webinar, Felt said there are available space systems that are capable of delivering capabilities to meet warfighting needs.

Frank Calvelli, assistant secretary of the Air Force for acquisition and integration, also sees the importance of speeding up the acquisition of more commercial technologies to boost the U.S. space capabilities, according to Felt.

“His formula for going faster in acquisition starts with smaller systems, and that includes buying more commercial systems,” Felt said.

Felt also noted that the Department of Defense’s investment strategy can have a significant effect on the space industry, adding that it can either be “super helpful” or “super harmful” to the industrial base.

2023 Space Acquisition Forum

Calvelli is set to share his thoughts on how to transform space acquisition to outpace U.S. competitors at GovCon Wire’s 2023 Space Acquisition Forum on Jan. 18. Click here to register.

/
NIH Splits CIO, Center for IT Director Roles
Published on
NIH Splits CIO, Center for IT Director Roles

The National Institutes of Health has separated the roles of the chief information officer and director of the Center for Information Technology following Andrea Norris’ retirement in December. She served for more than a decade in the dual-hatted role, Federal News Network reported Thursday.

Ivor D’Souza, director of information systems at the National Library of Medicine, serves as acting CIT director. Dennis Papula, deputy CIO at the NIH, serves as CIO on an interim basis.

“With Ms. Norris’ departure, we have the opportunity to reevaluate the technology leadership needs of the NIH. We view the roles of the CIT director and OCIO director as distinct,” a spokesperson for NIH told FNN in an email. 

“The director of CIT needs to focus on the unique needs of NIH’s research and clinical enterprise. And we hope to find an individual who can help the NIH institutes and centers advance their scientific goals,” the spokesperson added.

NIH has begun accepting applications for the CIT director position and the job opening will close on March 7. The agency has not yet published a job vacancy for the CIO role.

The spokesperson noted that the CIO post will focus more on security standards and compliance and that the NIH is looking for a leader with experience managing IT functions.

/
House Bill to Form Civilian Group of Cyber, Digital Experts
Published on
House Bill to Form Civilian Group of Cyber, Digital Experts

A bipartisan pair of House lawmakers has introduced legislation to establish a civilian organization that will work to address the digital and cybersecurity needs of federal government agencies.

The bill, introduced by Reps. Tony Gonzales, R-Texas, and Robin Kelly, D-Ill., would require the General Services Administration to manage and assign a group of individuals, called the National Digital Reserve Corps, to agencies that request support, Gonzales’ office said Wednesday.

It would allow reservists to work on digital and cybersecurity projects, digital education and training and technology development for the federal government for 30 days per calendar year over a three-year period.

The legislation would also provide the reservists the opportunity to obtain training and education and receive security clearances.

“The National Digital Reserve Corps strives to fill that void with civilian industry experts working in service to our federal government and our national security. This will bring the ingenuity and expertise of the private sector to our federal government to bolster our nation’s cybersecurity defense,” Gonzales said.

US DOD, Japan MOD Sign Bilateral Agreements to Foster Technology R&D, Secure Supply Chain
Published on
US DOD, Japan MOD Sign Bilateral Agreements to Foster Technology R&D, Secure Supply Chain

U.S. Secretary of Defense Lloyd Austin and Japanese Minister of Defense Hamada Yasukazu sealed two bilateral agreements to collaborate on technology research and defense supply chains.

The Department of Defense announced that the two officials signed a memorandum of understanding for research, development, test and evaluation projects, and a security of supply arrangement on Wednesday.

The legally binding RDT&E MOU is geared toward keeping the alliance ahead of technological advancements, it and also revises the Project for Cooperative Research MOU according to current standards of practice, laws and policies.

On the other hand, the non-binding SOSA provides the two agencies with a streamlined mechanism to mutually make urgent requests for industrial resources in the event of supply chain disruptions.

“To support U.S. forces and enhance Alliance cooperation towards these ends, the United States and Japan must focus our efforts to collaborate on sharpening the competitive edge of the Alliance to meet future force requirements and sustained logistics. This is a consequential moment for Japan and the U.S.-Japan Alliance as we embark on new forms of cooperation together,” said Austin, a two-time recipient of the Wash100 award.

/
Space Force Set to Launch New NSSL Mission On SpaceX Rocket; Maj. Gen. Stephen Purdy Quoted
Published on
Space Force Set to Launch New NSSL Mission On SpaceX Rocket; Maj. Gen. Stephen Purdy Quoted

The U.S. Space Force will launch its National Security Space Launch-67 mission using a SpaceX Falcon Heavy rocket on January 14 at 5:00 p.m.

Scheduled to lift off from the Kennedy Space Center, the mission consists of two co-manifested satellites designed to transmit military communications data and bring payloads to space, the Space Systems Command announced on Friday.

“This is a complex mission and truly represents what Assured Access to Space is about, and is why we’re so enthusiastic about this upcoming launch — our second Falcon Heavy in just months,” said Maj. Gen. Stephen Purdy, program executive officer for SSC’s Assured Access to Space organization.

“The teamwork I’ve seen preparing for this launch has just been exceptional. We’ve worked side-by-side with SpaceX to ensure all boxes are checked,” he emphasized.

As the launch’s forward spacecraft, SSC’s Continuous Broadcast Augmenting SATCOM will enter geosynchronous orbit to deliver communications relay capabilities that will aid the service’s senior leadership and combatant commanders. It is intended to augment existing military satellite communication capabilities and steadily broadcast military data using space-based satellite relay links.

Also included in the launch is the Long Duration Propulsive ESPA spacecraft, which will be used to quickly place various payloads into orbit, providing key data meant to inform and shape later Space Force initiatives. It carries two SSC payloads, catcher and WASSAT, as well as two Space Rapid Capabilities Office operational prototype payloads for enhanced situational awareness and an operational prototype crypto/interface encryption payload to ensure secure space-to-ground communications stability. 

This mission serves as the first launch for the NSSL initiative this year and the first SpaceX launch from the NSSL Phase 2 contract. It marks the fifth SpaceX Falcon Heavy mission overall and the rocket’s second NSSL mission.

In conducting this launch, the Space Force will harness the SpaceX-developed booster reusability capability, which allows the service to reuse side boosters from an earlier USSF mission.

A backup opportunity is scheduled for January 15 at 5:56 p.m.

Space Force Set to Launch New NSSL Mission On SpaceX Rocket; Maj. Gen. Stephen Purdy Quoted

GovCon Wire will be hosting its Space Acquisition Forum on Jan. 18, which will connect government officials and industry experts to consider the challenges, technologies and best practices shaping space acquisition today. To learn more and register to attend, please visit GovCon Wire’s events page.

/
AFWERX, Army Award 300+ Small Business Contracts in Multiservice Contracting Sprint
Published on
AFWERX, Army Award 300+ Small Business Contracts in Multiservice Contracting Sprint

AFWERX, the innovation arm of the Air Force Research Laboratory, has partnered with a pair of U.S. Army organizations to conduct a multiservice contracting sprint for small businesses developing technologies for potential military applications.

During the inaugural multiservice contracting sprint, more than 300 small businesses secured Small Business Innovation Research and Small Business Technology Transfer Phase I contracts, worth over $20 million in total, AFRL said Thursday.

The program, held from Oct. 24 to Nov. 4, 2022, was a collaborative effort between AFWERX and Army Futures Command and Army Contracting Command.

Army Applications Laboratory supported about 80 military and civilian contracting professionals from 21 states during the discovery and idea formulation process.

“Contracting sprints are just one activity wherein we can work effectively and efficiently as multiservice partners to get after common objectives, share knowledge and systematically implement continuous improvements,” said John McCanney, AFWERX contracting sprints lead.

/
Navy Secretary Carlos Del Toro Cites Need for Weapons Makers to Increase Production Rates
Published on
Navy Secretary Carlos Del Toro Cites Need for Weapons Makers to Increase Production Rates

Navy Secretary Carlos Del Toro said the U.S. may find it “challenging” to equip itself with weapons systems and help Ukraine in its fight against Russia if weapons manufacturers cannot ramp up production in the next six months to a year, Defense One reported Wednesday.

“With regards to deliveries of weapons systems for the fight in Ukraine…Yeah, that’s always a concern for us. And we monitor that very, very closely. I wouldn’t say we’re quite there yet, but if the conflict does go on for another six months, for another year, it certainly continues to stress the supply chain in ways that are challenging,” Del Toro told reporters at a conference in Arlington, Virginia.

He said Kathleen Hicks, deputy defense secretary and a two-time Wash100 awardee, has been collaborating with the defense industry to identify the challenges facing the companies and help them boost production.

“It’s obvious that you know, these companies have a substantial pipeline for the future,” Del Toro said. “They now need to invest in their workforce, as well as the capital investments that they have to make within their own companies to get their production rates up.”

Supplies are mainly coming from U.S. Army repositories rather than from the Navy, the article said.

Raytheon Technologies Leaders And Executives
Published on
Raytheon Technologies Leaders And Executives

Photo by Arnold O.A. Pinto from Shutterstock.com

The Raytheon Company is an American multinational defense corporation that manufactures various weapons, aircraft, and technologies for government and private sector use. Raytheon Technologies creates and distributes multiple military and security-related products, including engines, satellites, cybersecurity, and air defense systems.

Get to know the top Raytheon Technologies leaders and executives responsible for providing innovative solutions to businesses worldwide.

Who Are the Founders of Raytheon Technologies?

In 1922, three scientists and engineers in Cambridge, Massachusetts, named Laurence K. Marshall, Charles G. Smith, and Vannevar Bush established Raytheon under the American Appliance Company. The business initially focused on manufacturing cutting-edge refrigerant technologies, which eventually changed to electronics.

Where Is Raytheon Technologies Headquarters?

Raytheon Technologies relocated its headquarters from California to Arlington, Virginia. This move enables Raytheon to reinforce its connection within the government and commercial aerospace sphere.

Raytheon Technologies Leadership

Raytheon Technologies’ leaders and executives are made of experts and veterans in the government, technological, and aerospace industries.

Gregory J. Hayes, Chairman & Chief Executive Officer of Raytheon Technologies

Gregory J. Hayes, Chairman & Chief Executive Officer of Raytheon Technologies, Raytheon Technologies CEO

Gregory J. Hayes is currently serving as Raytheon Technologies Corporation’s chief executive officer and chairman of the board. In this position, he is responsible for leading and overlooking the defense and aerospace operations of the company.

Hayes has been a strong leader, having almost 21 years of experience at United Technologies Corporation since 2014. He has held several leadership roles in finance and business development. He was then elected as chairman of Raytheon’s board in 2021.

Roy Azevedo, President of Raytheon Intelligence & Space

Roy Azevedo, President of Raytheon Intelligence & Space

Roy Azevedo serves as Raytheon’s Intelligence & Space business sector president. He supervises the company’s portfolio, including advanced sensors and cyber and software solutions. He also serves as a board member in Raytheon’s branches in Saudi Arabia, Australia, and the United Kingdom.

Azevedo has over three decades of aerospace and defense leadership. Before his current position, he was Raytheon’s Intelligence, Surveillance, and Reconnaissance Systems’ vice president and general manager.

Barbara Borgonovi, Senior Vice President of Corporate Strategy & Development

Barbara Borgonovi, Senior Vice President of Corporate Strategy & Development

Barbara Borgonovi serves as senior vice president of Raytheon’s Strategy & Development. She oversees the company’s profitability and performance efforts and evaluates merger and acquisition options.

Borgonovi started working for Raytheon in 2001. Some positions she held before taking on the SVP role include supply chain, program management, operations management, and quality engineering.

In 2017, Barbara Borgonovi was named the Most Innovative Woman of the Year in Manufacturing, earning her the Gold Stevie Award.

Christopher Calio, Chief Operating Officer

Christopher Calio, Chief Operating Officer

Christopher Calio is the current Raytheon Technologies’ chief operating officer, responsible for the company’s business units. Calio has a wide range of experience in managing a business, making plans, and dealing with legal issues.

Before his current position, he served as the president of Pratt & Whitney. In 2005, he started working for the former United Technologies Company. He held several leadership roles, including vice president and Collins Aerospace (formerly known as UTC Aerospace Systems) general counsel.

Paolo Dal Cin, Senior Vice President of Operations, Supply Chain, Quality, EH&S

Paolo Dal Cin, Senior Vice President of Operations, Supply Chain, Quality, EH&S

Paolo Dal Cin is the senior vice president of Raytheon Technologies’ Operations, Supply Chain, Quality, Environment, and Health & Safety (EH&S). He oversees the company’s global security services and globally integrated manufacturing network.

Dal Cin has over two decades of experience in supply chain, engineering, and manufacturing. Before his current position, he led Col00lins Aerospace’s Operations & Quality.

Shane G. Eddy, President of Raytheon’s Pratt & Whitney

Shane G. Eddy, President of Raytheon's Pratt & Whitney

Shane G. Eddy currently serves as president of Raytheon Technologies’ subsidiary, Pratt & Whitney. He is in charge of the workforce in charge of developing and marketing aircraft power plants and auxiliary power systems.

Before joining Pratt & Whitney, Eddy was vice president and general manager for turboshaft and turboprop engines at GE Aviation. He also gained leadership positions in Sikorsky Aircraft and Bell Helicopter Textron.

He soon joined Pratt & Whitney as chief operations officer before becoming president. He was in charge of ensuring that the company’s original equipment manufacturing met all of its goals for safety, quality, on-time delivery, and cost.

Pamela Erickson, Senior Vice President, Chief Communications Officer

Pamela Erickson, Senior Vice President, Chief Communications Officer

Pamela Erickson serves as Raytheon’s Senior Vice President and Chief Communications Officer. She is responsible for the company’s Communications & Corporate Affairs, which include operations like public relations, global marketing, employee communications, digital platforms, and corporate social responsibility programs.

Erickson has nearly 30 years of expertise in communications helping the company build on its reputation, increasing shareholder value, and driving business growth. She was also Raytheon’s VP of global branding and corporate citizenship before its 2020 merger with UTC.

Wesley D. Kremer, President of Raytheon Missiles & Defense

Wesley D. Kremer, President of Raytheon Missiles & Defense

Wesley D. Kremer is the current president of Raytheon’s subsidiary, Raytheon Missiles & Defense. He is in charge of a wide range of defense technology, including anti-air and anti-missile systems, precision weapons, radars, command and control infrastructure.

Kremer has decades of experience as an executive in aerospace and defense. He is a U.S. Air Force veteran serving as the Air Force’s weapon systems officer on F-111 and F-15E aircraft.

Raja Maharajh, Executive Vice President, General Counsel

Raja Maharajh, Executive Vice President, General Counsel

Raja Maharajh is the current Raytheon Technologies’ general counsel. In this role, he is in charge of all legal and regulatory matters, such as lawsuits, ethics and compliance, and intellectual property.

Maharajh joined the company in 2004 and held several leadership roles, including being the Pratt & Whitney and Pratt & Whitney Commercial Engines’ general counsel. He also served as a primary adviser, helping the chairman, CEO, and senior executives make decisions and act efficiently.

Neil G. Mitchill Jr., Executive Vice President, Chief Financial Officer

Neil G. Mitchill Jr., Executive Vice President, Chief Financial Officer, cfo at raytheon technologies

Neil G. Mitchill Jr. serves as Raytheon Technologies’ chief financial officer and is responsible for all the company’s financial matters. It includes all aspects of the company’s financial planning and analysis, financial reporting, investor relations, tax, and internal audit.

Before his current position, he was formerly the vice president and chief financial officer of Pratt and Whitney business. Mitchill had 17 years of client service experience at PricewaterhouseCoopers LLP before joining the company.

Mark E. Russell, Senior Vice President, Chief Technology Officer

Mark E. Russell, Senior Vice President, Chief Technology Officer

Mark E. Russell is Raytheon Technologies’ senior vice president and chief technology officer. He oversees the company’s engineering operations and R&D investments, among other aspects of the company’s technological vision and strategy.

Russell has a wide range of experience serving as a technological leader in the aerospace and defense industries. Before Raytheon merged with United Technologies in 2020, he oversaw the company’s Engineering, Technology, and Mission Assurance division.

In 2020, Mark E. Russell was elected to the National Academy of Engineering (NAE) for his work on radar systems for national defense and safety. NAE is an honorary society that recognizes individuals who have made significant contributions to engineering in the areas of theory, practice, or education.

Jeff Shockey, Senior Vice President, Global Government Relations

Jeff Shockey, Senior Vice President, Global Government Relations

Jeff Shockey serves as Raytheon Technologies’ senior vice president for Global Government Relations. He’s responsible for dealing with international, federal, and state governments and articulating the company’s commercial objectives to legislators and other groups.

Shockey has over three decades of experience working with the government. Formerly, he served as vice president of global sales and marketing for Boeing’s defense, space, and security and international services’ government services portfolio. He was also a partner at Copeland, Lowery, Jacquez, Denton, Shockey & White and co-founded the public affairs and government relations firm S-3 Group.

Stephen J. Timm, President, Collins Aerospace

Stephen J. Timm, President, Collins Aerospace

Stephen Timm currently leads Collins Aerospace executives as the president. Collins Aerospace is a strategic business unit of Raytheon that works on avionics. He helps the company improve aviation electronics and data management technologies worldwide for military and commercial clients.

Before his current position, he oversaw the commercial avionics division as vice president. Timm has over twenty years of professional expertise in the aerospace and defense industries.

Dantaya Williams, Executive Vice President, Chief Human Resources Officer

Dantaya Williams, Executive Vice President, Chief Human Resources Officer

Dantaya Williams is the current Raytheon Technologies’ chief human resources officer at Raytheon Technologies. She oversees all aspects of talent acquisition, workplace diversity, employee engagement, overall rewards, and the employee experience relating to the company’s global Human Resources department.

Business Insider named Williams one of the top 33 most innovative HR executives. And because of her dedication as an HR executive, the Connecticut Women’s Education and Legal Fund awarded her the Maria Miller Stewart – One Woman Makes a Difference Award for 2019.

(Executive Photos from Raytheon Technologies Official Website)

Improved Intelligence in Defense Systems, where are raytheon headquarters?

Photo by JHVEPhoto from Shutterstock.com

Improved Intelligence in Defense Systems

Raytheon Technologies offers innovative solutions to its clients, giving them a competitive edge by accommodating their specific needs without sacrificing quality. Raytheon Technologies leaders and executives continue improving defense systems, providing a safe and sound tomorrow.

 

Pfizer Inc. Leaders, Founders, and Executives: Who Are They?
Published on
Pfizer Inc. Leaders, Founders, and Executives: Who Are They?

Image by YES Market Media from Shutterstock

Pfizer, Inc. is a leader in the pharmaceutical and biotechnology industries. The company is one of the largest developers and manufacturers of prescription medicines and vaccines for humans and animals. While it has been successfully creating pharmaceuticals in the past decades, manufacturing the COVID-19 vaccine with BioNTech, yielded massive profits for Pfizer, and more importantly, has given it an eminent standing in the U.S. healthcare space. Take a look at Pfizer Inc. leaders, founders, and executives.

About Pfizer Inc.

About Pfizer Inc.

“Pfizer World Headquarters Entrance,” by Coolcaesar, licensed under CC BY-SA 4.0

Pfizer Inc. produces pharmaceutical products for various biomedical science branches, such as immunology, oncology, and cardiology. The company sells its products and services in more than 125 countries, with most of its customers and revenue coming from the United States, China, and Japan.

As of November 1, 2022, Pfizer recorded a revenue of approximately $76 billion, with seven of its products accounting for over $1 billion in sales. The company has grown significantly through numerous government contracts worldwide to procure and distribute the Pfizer-BioNTech COVID-19 vaccine.

Where is Pfizer’s headquarters?

The headquarters of Pfizer Inc. is located on 42nd Street, Manhattan, New York City. The company operates ten manufacturing sites and two distribution centers in the U.S. and has global offices in over 50 countries.

What is Pfizer’s organizational structure?

Pfizer Inc. is organized into three primary business units to revitalize its innovation, elevate its core values, and maximize capital for patients and shareholders.

  1. Global Innovative Pharma Business develops commercial medicines to improve patients’ lives in therapeutic areas, such as Xeljanz, Eliquis, and Lyrica.
  2. Global Vaccines, Oncology, and Consumer Healthcare Business is responsible for high organic growth and operations in science, talent, and market approach.
  3. Global Established Pharma Business takes advantage of the diverse business opportunities for the company’s three primary product segments: Peri-LOE products, Legacy established products, and Emerging Markets.

Who founded Pfizer?

Pfizer Inc. Founder | Charles Pfizer

Photo from Wikimedia

The founders of Pfizer Inc. are cousins Charles Pfizer and Charles F. Erhart, who established a chemical compounds production business in Williamsburg, New York, around 1849. The company grew rapidly through the Civil War and doubled its revenue in 1869. The last Pfizer family member involved in the company was Emile Pfizer, the youngest son of Charles, who served as the President from 1906 to 1941.

Who are the top executives of Pfizer?

The executive leadership team comprises industry experts in medical, research-based pharmaceutical, and biomedical technologies. They lead a workforce of over 79,000 employees worldwide, working on 112 projects in the pipeline. Here’s a list of Pfizer Inc. executives and leaders.

Dr. Albert Bourla, Chief Executive Officer and Chairman

Dr. Albert Bourla, Chief Executive Officer and Chairman | Pfizer CEO

As the Pfizer Inc. CEO and Chairman, Dr. Albert Bourla leads Pfizer’s mission of creating a transformative impact on human health. He took office in January 2019 and has since headed the company’s patent products business, research and development, digital innovation, capabilities, and culture.

Bourla joined Pfizer in 1993 and has held numerous senior leadership positions, including

  • Vice President of Business Development and New Products Marketing (2004-2005)
  • President for Pfizer Animal Health in Europe, Africa, and Asia Pacific (2005-2010)
  • President & General Manager of Established Products Business Unit (2010-2013)
  • Group President of Vaccines, Oncology, & Consumer Healthcare (2014-2016)
  • Group President of Pfizer Innovative Health (2016-2017)
  • Chief Operating Officer (2017-2019)
  • Chief Executive Officer (2019-2021)

Before assuming office as Pfizer CEO, Bourla worked across eight cities on five continents. During his tenure at the company, he developed an understanding of the different healthcare needs worldwide, strengthening his commitment to bringing accessible medicines and vaccines.

Mikael Dolsten, M.D., Ph.D., Chief Scientific Officer and President of Worldwide Research, Development, and Medical

Mikael Dolsten, M.D., Ph.D., Chief Scientific Officer and President of Worldwide Research, Development, and Medical

Mikael Dolsten manages the company’s Portfolio Strategy and Investment Committee and is responsible for pipeline investments and research and development strategies. As the Chief Scientific Officer, he focuses on scientific breakthroughs for biotechnologies such as:

  • Small-molecule medicines
  • Biotherapeutics
  • Gene therapies
  • Vaccines

As the President of Worldwide Research, Development, and Medical (WRDM), Dolsten heads the development of compounds and provides pharmaceutical sciences to Pfizer’s marketed medicines and vaccines. He leads Pfizer research units under WRDM, responsible for oncology, internal medicine, and Centers for Therapeutic Innovation.

Angela Hwang, Chief Commercial Officer and President of Global Biopharmaceuticals Business

Angela Hwang, Chief Commercial Officer and President of Global Biopharmaceuticals Business

Angela Hwang serves as the Chief Commercial Officer and President of Global Biopharmaceuticals Business. The organization is responsible for Pfizer’s commercial efforts for significant health priorities, including cancer, COVID-19, infectious diseases, inflammation & immunology, and more.

Hwang leads the Pfizer Biopharma business unit to create more than 600 medicines, which benefited more than 1.4 billion people worldwide and generated over $82 billion in revenue in 2021. She pushes for advancements in pharmaceutical technologies with partnerships with payers and governments.

Dave Denton, Chief Financial Officer and Executive Vice President

Dave Denton, Chief Financial Officer and Executive Vice President

Dave Denton is a part of the executive leadership team (ELT), serving as Pfizer’s Chief Financial Officer and Executive Vice President. He is responsible for the company’s financial functions, such as auditing, taxation, insurance, and controllership. He joined the company in April 2022.

Denton’s addition to the ELT has delivered a fresh perspective to the company amid the evolving healthcare landscape. Before becoming Pfizer Inc. CFO, he had more than two decades of experience in the finance, operational, and healthcare industries working for companies such as Lowe’s Companies, CVS Health, and Deloitte.

William Pao, M.D., Ph.D., Chief Development Officer and Executive Vice President

William Pao, M.D., Ph.D., Chief Development Officer and Executive Vice President

William Pao joined Pfizer as the Chief Development Officer and Executive Vice President. in 2022. He manages Global Product Development, responsible for clinical developments, advancements, and research and development pipelines of the company’s marketed medicines and vaccines portfolio.

Before joining Pfizer, Pao was with Roche Pharma as the Head of Pharma Research and Early Development and Senior Vice President of Global Head Oncology Discovery and Translational Area. He also held several executive leadership positions at Vanderbilt University Medical Center and Memorial Sloan Kettering Cancer Center.

Mike McDermott, Chief Global Supply Officer and Executive Vice President

Mike McDermott, Chief Global Supply Officer and Executive Vice President

As the Chief Global Supply Officer and Executive Vice President at Pfizer, Mike McDermott oversees the entire product portfolio’s manufacturing and global supply chain. He manages Pfizer Global Supply and takes responsibility for the internal and external distribution of vaccines and medicines, accounting for more than 38 billion doses annually.

Previously, McDermott was with Wyeth as the Vice President of Site Operations before Pfizer acquired the company in 2009. After the acquisition, he became the Vice President of the Consumer Healthcare Operating Unit and had increasing responsibilities until assuming his current role in 2022.

Rady Johnson, Chief Compliance, Quality, & Risk Officer and Executive Vice President

Rady Johnson, Chief Compliance, Quality, & Risk Officer and Executive Vice President

Rady Johnson is Pfizer’s Chief Compliance, Quality, & Risk Officer and Executive Vice President. He manages the company’s compliance with global programs and organizations, such as Regulatory Quality Assurance, Office of the Ombuds, and other international security initiatives. He assumed office in December 2013.

Johnson joined Pfizer in 1994 as part of the legal team. He played a huge responsibility in the company’s Corporate Regulatory and Healthcare Law Audit, Global Products Counsel, and legal segments. His work earned him several recognitions, including the “Attorney Who Matters” award by Ethisphere Institute in 2015.

Sally Susman, Chief Corporate Affairs Officer and Executive Vice President

Sally Susman, Chief Corporate Affairs Officer and Executive Vice President

Sally Susman holds plenty of valuable responsibilities at Pfizer. She serves as the Chief Corporate Affairs Officer, Executive Vice President, Vice Chair of the Pfizer Foundation, and Pfizer’s Political Action Committee Co-Chair. Her responsibilities include leading the stakeholders, communications, government relations, and internal and external affairs.

Before joining Pfizer in 2007, Susman was with Estée Lauder Companies and American Express Company, where she held senior leadership roles for communications and government relations. She serves on the board of directors for UL Solutions and The International Rescue Committee.

Payal Sahni Becher, Chief People Experience Officer and Executive Vice President

Payal Sahni Becher, Chief People Experience Officer and Executive Vice President

As the Chief People Experience Officer and Executive Vice President, Payal Sahni heads Pfizer’s global talent strategies, ensures diversity and inclusion in the workforce, and improves company experiences through total rewards. She was promoted and has been serving in the position since January 2022.

Sahni joined Pfizer’s human resources team in 1997 and has held various senior leadership positions, such as Chief Human Resources Officer and Senior Vice President of Human Resources. One of her most significant contributions was spearheading the company’s transformative culture amid multiple mergers and acquisitions.

Lidia Fonseca, Chief Digital and Technology Officer and Executive Vice President

Lidia Fonseca, Chief Digital and Technology Officer and Executive Vice President

Lidia Fonseca is responsible for Pfizer’s comprehensive digital strategies as the Chief Digital and Technology Officer and Executive Vice President. She is responsible for leading technology products and solutions, digitizing drug discovery, clinical development, and commercial manufacturing and distribution.

During her tenure at Pfizer, Fonseca spearheaded using digital and healthcare technologies through automation, robotics, advanced data analytics, and artificial intelligence. She is responsible for the company’s launch of Learning and Development, Business Process Excellence, and Digital Companion.

Bill Carapezzi, Executive Vice President of Global Business Services and Transformation

Bill Carapezzi, Executive Vice President of Global Business Services and Transformation

As the Executive Vice President of Global Business Services and Transformation, Bill Carapezzi helps in managing various departments at Pfizer, including global procurement, global financial shared services, human resources operations, real estate, commercial operations, and more. He has been with the company since 2008.

Doug Lankler, General Counsel and Executive Vice President

Doug Lankler, General Counsel and Executive Vice President

Doug Lankler is the General Counsel and Executive Vice President at Pfizer. He joined the company in 1999 and assumed the Chief Compliance and Risk Officer role in 2006. Before joining the company, he had extensive public service experience as an assistant attorney at the U.S. Department of Justice in the Southern District of New York.

(Executive Photos from Pfizer Official Website)

Who are the key people on the board of directors for Pfizer?

Pfizer Inc. leadership team also composes of directors responsible for making crucial decisions about the company. Here’s the list of Pfizer Inc. Board of Directors.

  • Dr. Albert Bourla, Chief Executive Officer and Chairman
  • Shantanu Narayen, Lead Independent Director
  • Ronald E. Blaylock
  • Joseph J. Echevarria
  • Susan Hockfield, Ph.D.
  • Suzanne Nora Johnson
  • Susan Desmond-Hellmann, M.D., M.P.H
  • Scott Gottlieb, M.D.
  • Dan R. Littman, M.D., Ph.D.
  • James Quincey
  • Helen H. Hobbs, M.D.
  • James C. Smith

Relentless Pursuits of Breakthroughs To Change Patients’ Lives

Executive leadership team of Pfizer

Image by diy13 from Shutterstock

Pfizer Inc. leaders, founders, and executives have created critical products, especially amid the COVID-19 pandemic. The company continues to make relentless breakthroughs to change peoples’ lives and create a healthier world.

 

1 … 648 649 650 651 652 … 2,622